Complement Factor H
-
Subject Areas on Research
- A 32 kb critical region excluding Y402H in CFH mediates risk for age-related macular degeneration.
- A Therapeutic Antibody for Cancer, Derived from Single Human B Cells.
- Adrenomedullin and its binding protein attenuate the proinflammatory response after hemorrhage.
- CFH and VIPR2 as susceptibility loci in choroidal thickness and pachychoroid disease central serous chorioretinopathy.
- Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration.
- Complement Factor H Antibodies from Lung Cancer Patients Induce Complement-Dependent Lysis of Tumor Cells, Suggesting a Novel Immunotherapeutic Strategy.
- Complement Factor H Inhibits CD47-Mediated Resolution of Inflammation.
- Complement factor H autoantibodies are associated with early stage NSCLC.
- Complement factor H in AMD: Bridging genetic associations and pathobiology.
- Complement factor H increases risk for atrophic age-related macular degeneration.
- Complement factor H variant increases the risk of age-related macular degeneration.
- Enhanced CDC of B cell chronic lymphocytic leukemia cells mediated by rituximab combined with a novel anti-complement factor H antibody.
- Ethnic variation in early age-related macular degeneration lesions between white Australians and Singaporean Asians.
- Expression of human complement factor H prevents age-related macular degeneration-like retina damage and kidney abnormalities in aged Cfh knockout mice.
- Genetic Polymorphisms of CFH and ARMS2 Do Not Predict Response to Antioxidants and Zinc in Patients with Age-Related Macular Degeneration: Independent Statistical Evaluations of Data from the Age-Related Eye Disease Study.
- Genetic determinants of age-related macular degeneration in diverse populations from the PAGE study.
- Haplotypes spanning the complement factor H gene are protective against age-related macular degeneration.
- Heparan sulfate, including that in Bruch's membrane, inhibits the complement alternative pathway: implications for age-related macular degeneration.
- Human complement factor H Y402H polymorphism causes an age-related macular degeneration phenotype and lipoprotein dysregulation in mice.
- Incidence of Age-Related Macular Degeneration in a Multi-Ethnic United States Population: The Multi-Ethnic Study of Atherosclerosis.
- Increased plasma complement factor H is associated with geriatric depression.
- Independent effects of complement factor H Y402H polymorphism and cigarette smoking on risk of age-related macular degeneration.
- Inflammation, complement factor h, and age-related macular degeneration: the Multi-ethnic Study of Atherosclerosis.
- Insights into the genetic architecture of early stage age-related macular degeneration: a genome-wide association study meta-analysis.
- LOC387715/HTRA1 and complement factor H variants in patients with age-related macular degeneration seen at the mayo clinic.
- Lens status influences the association between CFH polymorphisms and age-related macular degeneration: findings from two population-based studies in Singapore.
- Molecular Docking and Molecular Dynamics (MD) Simulation of Human Anti-Complement Factor H (CFH) Antibody Ab42 and CFH Polypeptide.
- Molecular medicine: Defence against oxidative damage.
- Neovascular age-related macular degeneration and its association with LOC387715 and complement factor H polymorphism.
- Peripheral reticular pigmentary change is associated with complement factor H polymorphism (Y402H) in age-related macular degeneration.
- Rapid and sensitive method for detection of Y402, H402, I62, and V62 variants of complement factor H in human plasma samples using mass spectrometry.
- Regulation of age-related macular degeneration-like pathology by complement factor H.
- Shared genetic variants for polypoidal choroidal vasculopathy and typical neovascular age-related macular degeneration in East Asians.
- Single-Nucleotide Polymorphisms Associated With Age-Related Macular Degeneration and Lesion Phenotypes in the Comparison of Age-Related Macular Degeneration Treatments Trials.
- The ARMS2 A69S variant and bilateral advanced age-related macular degeneration.
- The discovery and early validation of novel plasma biomarkers in mild-to-moderate Alzheimer's disease patients responding to treatment with rosiglitazone.
- The role of complement dysregulation in AMD mouse models.